Hutchmed China Limited's ability to collect accounts receivable sequentially worsen to 3.6, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Hutchmed China Limited's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 101 days, from 92 days, in the 0 quarter.

If we take a look into Healthcare sector 457 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 3127 to 3196.

What is Receivable Turnover Ratio?
What is Hutchmed China Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HCM Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-16.07 %	-16.07 %	611.89 %	-16.07 %	470.8 %
Y / Y Revenue Change	-12.96 %	-	-	-	-24.8 %
Receivable Turnover Ratio (TTM)	3.6	3.97	3.81	5.13	4.87
HCM's Total Ranking	# 3196	# 3127	#	#	#
Accounts Receivable average collection period days	101	92	96	71	75
Seq. Receivable Change	0 %	-30.59 %	44.08 %	-16.07 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 141
Healthcare Sector	# 458
Overall Market	# 3196

Receivable Turnover Ratio Statistics
High	Average	Low
17806.4	5687.18	4.05
(Dec 31 2021)		(Dec 31 2024)

HCM Company Profile • Back to HCM Efficiency Comparisons • Compare HCM Receivables Turnover Ratio to its Competitors

Financial Statements
Hutchmed China Limited's Accounts Receivable	$ 137 Millions	Visit HCM's Balance sheet
Hutchmed China Limited's Sales TTM	$ 549 Millions	Visit HCM's Income Statement
Sources of HCM's Revenues		Visit HCM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HCM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HCM's Growth Rates	HCM's Roa	HCM's Inventory Turnover Ratio	HCM's Dividend Comparisons
HCM's Profitability Ratios	HCM's Roi	HCM's Asset Turnover Ratio	HCM's Dividend Growth
HCM's Valuation Ratios	HCM's Roe	HCM's Financial Strength Ratios	HCM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Uniqure N v	10.98	$ 16.098 Millions	$ 1.466 Millions
Inmed Pharmaceuticals Inc	10.98	$ 4.507 Millions	$ 0.410 Millions
National Healthcare Corp	10.93	$ 1,517.781 Millions	$ 138.813 Millions
Novavax inc	10.92	$ 1,123.479 Millions	$ 102.881 Millions
Vivos Therapeutics Inc	10.91	$ 16.542 Millions	$ 1.517 Millions
Exact Sciences Corporation	10.49	$ 3,245.310 Millions	$ 309.460 Millions
Bioaffinity Technologies Inc	10.37	$ 6.162 Millions	$ 0.594 Millions
Bioxcel Therapeutics Inc	10.27	$ 0.642 Millions	$ 0.063 Millions
Utah Medical Products Inc	10.25	$ 38.001 Millions	$ 3.706 Millions
Integrated Biopharma Inc	10.25	$ 51.068 Millions	$ 4.981 Millions
Viemed Healthcare Inc	10.17	$ 270.280 Millions	$ 26.585 Millions
Addus Homecare Corp	10.15	$ 1,421.874 Millions	$ 140.113 Millions
Biolife Solutions Inc	10.11	$ 96.118 Millions	$ 9.506 Millions
Radnet Inc	10.06	$ 2,040.210 Millions	$ 202.746 Millions
Aquestive Therapeutics Inc	10.03	$ 44.545 Millions	$ 4.441 Millions
Edap Tms Sa	10.03	$ 166.111 Millions	$ 16.564 Millions
Veracyte Inc	9.94	$ 489.532 Millions	$ 49.270 Millions
Sanuwave Health Inc	9.92	$ 44.051 Millions	$ 4.439 Millions
Sunshine Biopharma Inc	9.91	$ 36.306 Millions	$ 3.662 Millions
Madrigal Pharmaceuticals Inc	9.87	$ 958.403 Millions	$ 97.105 Millions
International Stem Cell Corporation	9.86	$ 9.100 Millions	$ 0.923 Millions
Blue Water Vaccines Inc	9.85	$ 0.815 Millions	$ 0.083 Millions
Kestra Medical Technologies Ltd	9.85	$ 79.728 Millions	$ 8.092 Millions
Sol gel Technologies Ltd	9.85	$ 19.388 Millions	$ 1.968 Millions
Lensar Inc	9.68	$ 58.435 Millions	$ 6.038 Millions
Encompass Health Corporation	9.63	$ 5,935.200 Millions	$ 616.475 Millions
Biodesix Inc	9.62	$ 88.499 Millions	$ 9.200 Millions
Tandem Diabetes Care Inc	9.54	$ 1,011.039 Millions	$ 106.022 Millions
Acadia Pharmaceuticals Inc	9.51	$ 1,071.505 Millions	$ 112.639 Millions
Irhythm Holdings Inc	9.49	$ 746.250 Millions	$ 78.664 Millions

Date modified: 2026-10-05T11:03:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.